Provided by Tiger Trade Technology Pte. Ltd.

Twist Bioscience Corp

44.50
+2.435.78%
Post-market: 44.01-0.4900-1.10%17:28 EDT
Volume:1.77M
Turnover:78.03M
Market Cap:2.72B
PE:-35.03
High:45.57
Open:44.18
Low:43.35
Close:42.07
52wk High:57.88
52wk Low:23.30
Shares:61.15M
Float Shares:59.26M
Volume Ratio:1.87
T/O Rate:2.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2703
EPS(LYR):-1.2987
ROE:-16.79%
ROA:-13.49%
PB:5.97
PE(LYR):-34.27

Loading ...

Twist Bioscience Introduces New Plasmid DNA Preparation Products

MT Newswires Live
·
Dec 04, 2025

Miss These Genesis Mission Stocks, and You’ll Regret It for a Decade

InvestorPlace
·
Dec 02, 2025

Director Jan Johannessen Reports Disposal of Twist Bioscience Common Shares

Reuters
·
Nov 21, 2025

Stock Track | Twist Bioscience Plummets 5.06% as New Manufacturing Risk Overshadows Ark Invest's Purchase

Stock Track
·
Nov 18, 2025

Stock Track | Twist Bioscience Plummets 5.06% on Manufacturing Scaling Risk Disclosure

Stock Track
·
Nov 18, 2025

Twist Bioscience Faces Scaling Challenges: Potential Impact on Future Demand and Financial Health

TIPRANKS
·
Nov 18, 2025

Cathie Wood Bets Big on This Peter Thiel-Backed Coinbase Rival as Bitcoin Crashes Below $91,000

Benzinga
·
Nov 18, 2025

Twist Bioscience Is Maintained at Overweight by Barclays

Dow Jones
·
Nov 17, 2025

Stock Track | Twist Bioscience Plummets 5.10% Pre-Market After Barclays Cuts Target Price

Stock Track
·
Nov 17, 2025

Will MRD Express and Margin Gains Change the Growth Trajectory for Twist Bioscience (TWST)?

Simply Wall St.
·
Nov 16, 2025

Twist Bioscience Shares Slide to Lowest in Two Years Following 4Q Loss

Dow Jones
·
Nov 15, 2025

Twist Bioscience Down Nearly 11%, On Track for Largest Percent Decrease Since August 2024 -- Data Talk

Dow Jones
·
Nov 15, 2025

Twist Bioscience Eyes Profit Turnaround In 2026 After Narrowing Losses

Benzinga
·
Nov 15, 2025

Twist Bioscience Corporation publishes ESG report

Reuters
·
Nov 15, 2025

Stock Track | Twist Bioscience Plummets 19.53% as Q4 Earnings Miss and Cautious 2026 Outlook Rattle Investors

Stock Track
·
Nov 14, 2025

Stock Track | Twist Bioscience Plummets 19.53% on Q4 Earnings Miss and Cautious 2026 Guidance

Stock Track
·
Nov 14, 2025

Stock Track | Twist Bioscience Plunges 7.66% Pre-Market on Earnings Miss and Soft Guidance

Stock Track
·
Nov 14, 2025

Stock Track | Twist Bioscience Plunges 7.66% Pre-market on Q4 Earnings Miss and Cautious Guidance

Stock Track
·
Nov 14, 2025

GUIDANCE: (TWST) Twist Bioscience Expects Fiscal 2026 Total Revenue Range $425M to $435M, vs. FactSet Est of $431.9M

MT Newswires Live
·
Nov 14, 2025

Twist Bioscience reports record $376.6 million revenue for fiscal 2025

Reuters
·
Nov 14, 2025